Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

PubWeight™: 3.19‹?› | Rank: Top 1%

🔗 View Article (PMC 104609)

Published in J Clin Microbiol on March 01, 1998

Authors

F Gamboa1, G Fernandez, E Padilla, J M Manterola, J Lonca, P J Cardona, L Matas, V Ausina

Author Affiliations

1: Servicio de Microbiologia, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain.

Articles citing this

Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol (1999) 4.10

Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One (2008) 3.07

Comparative evaluation of the new gen-probe Mycobacterium tuberculosis amplified direct test and the semiautomated abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol (1998) 2.55

Comparison of enhanced Mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol (2000) 2.54

Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol (2003) 2.32

Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax (2006) 2.20

Performance assessment of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex from respiratory and extrapulmonary specimens. J Clin Microbiol (2002) 2.03

Comparison of the real-time PCR method and the Gen-Probe amplified Mycobacterium tuberculosis direct test for detection of Mycobacterium tuberculosis in pulmonary and nonpulmonary specimens. J Clin Microbiol (2004) 1.68

Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates. J Clin Microbiol (1999) 1.61

Evaluation of the LiPA MYCOBACTERIA assay for identification of mycobacterial species from BACTEC 12B bottles. J Clin Microbiol (2000) 1.57

Evaluation of Gen-Probe amplified mycobacterium tuberculosis direct test by using respiratory and nonrespiratory specimens in a tertiary care center laboratory. J Clin Microbiol (2002) 1.56

Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis (2005) 1.55

Clinical Evaluation of the Gen-Probe amplified mycobacterium tuberculosis direct test for rapid detection of Mycobacterium tuberculosis in select nonrespiratory specimens. J Clin Microbiol (2001) 1.50

Rapid and specific detection of Mycobacterium tuberculosis by using the Smart Cycler instrument and a specific fluorogenic probe. J Clin Microbiol (2003) 1.46

Rapid and specific detection of Mycobacterium tuberculosis from acid-fast bacillus smear-positive respiratory specimens and BacT/ALERT MP culture bottles by using fluorogenic probes and real-time PCR. J Clin Microbiol (2002) 1.40

Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.31

Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. J Clin Microbiol (2003) 1.28

Evaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study. J Clin Microbiol (2003) 1.12

Practical strategies for performance optimization of the enhanced gen-probe amplified mycobacterium tuberculosis direct test. J Clin Microbiol (2004) 1.07

Clinical evaluation of the gen-probe amplified mycobacterium tuberculosis direct test for rapid diagnosis of tuberculosis lymphadenitis. J Clin Microbiol (2004) 0.95

PCR-hybridization assay for Mycobacterium avium complex: optimization of detection in peripheral blood from humans. J Clin Microbiol (2001) 0.86

Novel real-time simultaneous amplification and testing method to accurately and rapidly detect Mycobacterium tuberculosis complex. J Clin Microbiol (2012) 0.84

Use of the Gen-Probe amplified mycobacterium tuberculosis direct test for early detection of Mycobacterium tuberculosis in BACTEC 12B medium. J Clin Microbiol (2001) 0.83

Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis. J Clin Microbiol (2008) 0.81

False-negative results obtained with the Gen-Probe Amplified Mycobacterium tuberculosis direct test caused by unrecognized inhibition of the amplification reaction. J Clin Microbiol (2009) 0.79

Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis. J Clin Microbiol (2003) 0.78

Polymerase chain reaction in the diagnosis of tuberculosis. Indian J Clin Biochem (2000) 0.75

Molecular Mycobacteriology and Expansion in Disease Diagnosis. Indian J Clin Biochem (2015) 0.75

Clinical Impact of Nucleic Acid Amplification Testing in the Diagnosis of Mycobacterium Tuberculosis: A 10-Year Longitudinal Study. Open Forum Infect Dis (2017) 0.75

Use of amplified Mycobacterium tuberculosis direct test in respiratory samples from HIV-infected patients in Brazil. J Bras Pneumol (2014) 0.75

Evaluation of the results of Mycobacterium tuberculosis direct test (MTD) and Mycobacterial culture in urine samples. Braz J Microbiol (2008) 0.75

Inhibitory effect of Alpha-Tec XPR-plus phosphate buffer on the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct test. J Clin Microbiol (1999) 0.75

Articles cited by this

Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples. Lancet (1989) 11.38

Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory. J Clin Microbiol (1993) 6.65

Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol (1993) 6.38

Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation. Lancet (1991) 6.37

Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis. J Clin Microbiol (1991) 5.99

Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification. J Clin Microbiol (1990) 5.89

Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis: a blind comparison study among seven laboratories. J Clin Microbiol (1994) 5.84

Polymerase chain reaction for detection of Mycobacterium tuberculosis. J Clin Microbiol (1990) 5.55

A more reliable PCR for detection of Mycobacterium tuberculosis in clinical samples. J Clin Microbiol (1994) 5.43

Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria. J Clin Microbiol (1992) 4.55

Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1993) 4.04

Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture. J Clin Microbiol (1991) 3.88

Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol (1996) 3.85

Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by a target-amplified test system. J Clin Microbiol (1994) 3.81

Direct detection of Mycobacterium tuberculosis complex in respiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test and Roche Amplicor Mycobacterium Tuberculosis Test. J Clin Microbiol (1995) 3.28

Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. J Clin Microbiol (1991) 3.00

Screening of respiratory tract specimens for the presence of Mycobacterium tuberculosis by using the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1994) 2.94

Reliability of nucleic acid amplification for detection of Mycobacterium tuberculosis: an international collaborative quality control study among 30 laboratories. J Clin Microbiol (1996) 2.44

Comparative evaluation of two commercial amplification assays for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol (1997) 2.19

The rapid diagnosis of tuberculosis: a selective review. J Lab Clin Med (1990) 1.97

Detection of Mycobacterium tuberculosis DNA in clinical samples by using a simple lysis method and polymerase chain reaction. J Clin Microbiol (1993) 1.96

Diagnosis of extrapulmonary tuberculosis by Gen-Probe amplified Mycobacterium tuberculosis direct test. J Clin Microbiol (1996) 1.58

Simple method for production of internal control DNA for Mycobacterium tuberculosis polymerase chain reaction assays. J Clin Microbiol (1993) 1.52

Direct detection of Mycobacterium tuberculosis complex in nonrespiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1997) 1.52

Evaluation of a commercial rRNA amplification assay for direct detection of Mycobacterium tuberculosis in processed sputum. Eur J Clin Microbiol Infect Dis (1994) 1.27

[Media and methods of culture suitable for the reanimation and multiplication in vitro of Mycobacterium tuberculosis of reduced vitality, of ephemeral viability, or in a state of quiescence]. Ann Inst Pasteur (Paris) (1960) 1.11

Articles by these authors

Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest (2001) 3.28

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16

[Helicobacter pylori: an etiologic factor in chronic gastritis, gastroduodenal ulcer and gastric cancer]. Med Clin (Barc) (1995) 3.09

Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria. J Clin Microbiol (1991) 3.00

[Current status of tuberculosis in Spain. A precarious health care perspective with regard to developed countries]. Med Clin (Barc) (1995) 2.58

Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest (1993) 2.56

CT findings associated with Eagle syndrome. AJNR Am J Neuroradiol (2001) 2.42

Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. Chest (1998) 2.16

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08

Outcome after a "perfect" Fontan operation. Circulation (1990) 2.06

Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J (1999) 1.93

Prospective study of community-acquired pneumonia of bacterial etiology in adults. Eur J Clin Microbiol Infect Dis (1999) 1.88

The professional public health worker: educational and demographic profiles. Am J Public Health (1975) 1.80

Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial (2001) 1.79

Evaluation of a new serodiagnostic tuberculosis test based on immunoglobulin A detection against Kp-90 antigen. Int J Tuberc Lung Dis (2000) 1.64

Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis. Eur Respir J (2010) 1.58

Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol (1998) 1.57

Direct detection of Mycobacterium tuberculosis complex in nonrespiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1997) 1.52

Evaluation of the semiautomated Abbott LCx Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis in respiratory specimens. J Clin Microbiol (1997) 1.51

Evaluation of a rapid immunochromatographic assay for the detection of Legionella antigen in urine samples. Eur J Clin Microbiol Infect Dis (1999) 1.50

[Drug resistance in Mycobacterium tuberculosis. A multicenter study of the Barcelona area. Grupo de Trabajo sobre Resistencias en Tuberculosis]. Med Clin (Barc) (2000) 1.48

Treatment of pulmonary disease caused by Mycobacterium kansasii: results of 18 vs 12 months' chemotherapy. Tuber Lung Dis (1995) 1.46

Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration. J Clin Microbiol (1996) 1.44

[Protected bronchoalveolar lavage: a new endoscopic method in the diagnosis of bacterial pneumonia]. Med Clin (Barc) (1991) 1.40

[Factors associated with pleural thickening in pleural tuberculosis. Review of 99 cases]. An Med Interna (1996) 1.39

[Complications in Mediterranean boutonneuse fever: prospective study of 78 patients]. Rev Clin Esp (1989) 1.39

Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis (1998) 1.39

Rapid diagnosis of Staphylococcus aureus bacteremia using S. aureus PNA FISH. Eur J Clin Microbiol Infect Dis (2004) 1.33

The intravenous model of murine tuberculosis is less pathogenic than the aerogenic model owing to a more rapid induction of systemic immunity. Scand J Immunol (1999) 1.30

Middle cerebral artery occlusion in the mouse by intraluminal suture coated with poly-L-lysine: neurological and histological validation. Brain Res (1999) 1.26

Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children. J Clin Microbiol (2003) 1.26

Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother (1996) 1.24

Rapid diagnosis of extrapulmonary tuberculosis by ligase chain reaction amplification. J Clin Microbiol (1998) 1.22

Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries. Eur J Clin Microbiol Infect Dis (2010) 1.21

Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients. Chest (1991) 1.21

Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Majorcan hospitals: high prevalence of the epidemic clone EMRSA-15. Clin Microbiol Infect (2007) 1.21

Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis. Scand J Immunol (2000) 1.20

Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol (1998) 1.19

Evaluation of a fluorescence hybridisation assay using peptide nucleic acid probes for identification and differentiation of tuberculous and non-tuberculous mycobacteria in liquid cultures. Eur J Clin Microbiol Infect Dis (2000) 1.17

Utility of an in-house mycobacteriophage-based assay for rapid detection of rifampin resistance in Mycobacterium tuberculosis clinical isolates. J Clin Microbiol (2003) 1.16

Endothelin B receptor mediates ET-1 effects on cAMP and PGE2 accumulation in rat IMCD. Am J Physiol (1993) 1.15

Inhibitory effect of sodium dodecyl sulfate in detection of Mycobacterium tuberculosis by amplification of rRNA. J Clin Microbiol (1995) 1.14

GenoType MTBDRsl for molecular detection of second-line-drug and ethambutol resistance in Mycobacterium tuberculosis strains and clinical samples. J Clin Microbiol (2011) 1.13

Osmolar regulation of endothelin-1 production by rat inner medullary collecting duct. J Clin Invest (1993) 1.10

Assessment of in-vitro efficacy of 1% Virkon against bacteria, fungi, viruses and spores by means of AFNOR guidelines. J Hosp Infect (2000) 1.10

The size of the pulmonary arteries and the results of the Fontan operation. J Thorac Cardiovasc Surg (1989) 1.07

Fine-needle aspiration cytology of renal-cell adenocarcinoma metastatic to the breast: A report of three cases. Diagn Cytopathol (1999) 1.07

Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology (2000) 1.04

Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating intracellular free calcium levels through a protein kinase Cdelta-dependent pathway. Endocrinology (2000) 1.03

Comparison of a nonradiometric system with Bactec 12B and culture on egg-based media for recovery of mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis (1998) 1.03

Blastocystis hominis chronic diarrhoea in AIDS patients. Lancet (1989) 1.02

Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI. Vaccine (2009) 1.01

Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol (2011) 1.01

Comparison of radioimmunoassay and enzyme immunoassay kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples. J Clin Microbiol (1997) 1.01

Performance of VITEK-2 Compact and overnight MicroScan panels for direct identification and susceptibility testing of Gram-negative bacilli from positive FAN BacT/ALERT blood culture bottles. Clin Microbiol Infect (2009) 1.00

A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest (1993) 1.00